1-2 of 2
Ulrike Philippar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL

Min Xia, Liron David, Matt Teater, Johana Gutierrez, Xiang Wang, Cem Meydan, Andrew Lytle, Graham W. Slack, David W. Scott, Ryan D. Morin, Ozlem Onder, Kojo S.J. Elenitoba-Johnson, Nahuel Zamponi, Leandro Cerchietti, Tianbao Lu, Ulrike Philippar, Lorena Fontan, Hao Wu, Ari M. Melnick
Journal: Cancer Discovery
Cancer Discov (2022) 12 (8): 1922–1941.
https://doi.org/10.1158/2159-8290.CD-21-1566
Published: 05 August 2022
View articletitled, BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL
Open the PDF for BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL in another window
Includes: Multimedia, Supplementary data
Journal Articles

Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors

Erick J. Morris, Sharda Jha, Clifford R. Restaino, Priya Dayananth, Hugh Zhu, Alan Cooper, Donna Carr, Yongi Deng, Weihong Jin, Stuart Black, Brian Long, Jenny Liu, Edward DiNunzio, William Windsor, Rumin Zhang, Shuxia Zhao, Minilik H. Angagaw, Elaine M. Pinheiro, Jagdish Desai, Li Xiao, Gerald Shipps, Alan Hruza, James Wang, Joe Kelly, Sunil Paliwal, Xiaolei Gao, Boga Sobhana Babu, Liang Zhu, Pierre Daublain, Ling Zhang, Bart A. Lutterbach, Marc R. Pelletier, Ulrike Philippar, Phieng Siliphaivanh, David Witter, Paul Kirschmeier, W. Robert Bishop, Daniel Hicklin, D. Gary Gilliland, Lata Jayaraman, Leigh Zawel, Stephen Fawell, Ahmed A. Samatar
Journal: Cancer Discovery
Cancer Discov (2013) 3 (7): 742–750.
https://doi.org/10.1158/2159-8290.CD-13-0070
Published: 10 July 2013
View articletitled, Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors
Open the PDF for Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors in another window
Includes: Supplementary data